United States · FDA National Drug Code directory
brivaracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-1588_dd7c5f3e-5cd5-4219-bf1a-7fe15b291998
- Product NDC
- 70710-1588
- Form
- TABLET, FILM COATED
- Composition / generic term
- brivaracetam
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260221
- Source listing expiry
- 20271231
Source-listed ingredients
- BRIVARACETAM — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (70710-1588-4) / 1 TABLET, FILM COATED in 1 BLISTER PACK (70710-1588-7) · 70710-1588-4
- 60 TABLET, FILM COATED in 1 BOTTLE (70710-1588-6) · 70710-1588-6
- 180 TABLET, FILM COATED in 1 BOTTLE (70710-1588-8) · 70710-1588-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →